Table 2.
PT | Peritoneal findings at 1st surgery | Additional biopsies after 1st surgerya | Peritoneal findings at the same time as GP | Interval between 1st & 2nd surgeries | Reason for 2nd surgery | Chemotherapy before 2nd surgery | Chemoradiation after 2nd surgery | Follow-up duration after diagnosis of GP or gliomab | Additional findings |
---|---|---|---|---|---|---|---|---|---|
3c | NA | IT | GP | 24 months | Disease progressiond | Yes, BEP and mored | Radiation | ANED, 68 months | NA |
9 | NA | NA | GP | 182 months | Abdominal and pelvic paine | No | No | ANED, 1.5 months | NA |
10c | IT, MT | MT (liver mass) | GP, MT | 10 months | Residual masses (CT) | Yes, BEP 6 cycles | No | ANED, 36 months | GTSf |
11 | NA | NA | GP | 4 months | FDG-avid lesion (PET-CT) | No | No | ANED, 11 months | Encephalitisg |
12c | IT | NA | GP | 4 months | Peritoneal thickening (CT) | Yes, BEP 3 cycles | Yes, interferon | AWD, 25 months | GTSh |
15c | IT | NA | GP, glioma, IT, MT | 6 months | Sheet-like nodularity along the peritoneum and omental cake (CT and MRI). | Yes, EP/PE 4 cycles | Yes, HIPEC and radiation | AWD, 4 months | NA |
Abbreviations: PT = patient; NA = not available; GP = gliomatosis peritonei; MT = mature teratoma; IT = immature teratoma; BEP = bleomycin, etoposide, cisplatin; EP/PE = etoposide and cisplatin chemotherapy; ANED = alive with no evidence of disease; AWD = alive with disease; ADSU = alive disease status unknown; GTS = growing teratoma syndrome; FDG = fludeoxyglucose F 18; PET = positron emission tomography; CT = computerized tomography; MRI = magnetic resonance imaging; HIPEC = hyperthermic intraperitoneal chemotherapy.
Biopsies performed after the first surgery, but before the diagnosis of GP.
Please refer to Table 1 for the follow-up duration after diagnosis of primary ovarian neoplasms.
Patients #3, #10, #12 and #15 had ascites. However, time course of development of ascites suggested its association with either primary ovarian neoplasm or metastatic immature teratoma.
Because patient had disease progression while on BEP, she also received paclitaxel, ifosfamide, and cisplatin for 3 courses.
It was unclear whether abdominal and pelvic pain was associated with gliomatosis peritonei or endometriosis. The patient was previously diagnosed with endometriosis clinically, but it was never confirmed by pathology. Endometriosis was not present in all available pathology specimen.
Patient developed growing teratoma syndrome after chemotherapy, and had multiple masses in the abdomen and pelvis. Biopsy of 7.5-centimeter liver mass showed mature teratoma.
Patient developed anti-NMDA receptor encephalitis.
After the secondary surgery, patient was diagnosed as growing teratoma syndrome. Follow-up CT scan showed bilateral subdiaphragmatic implants encasing the liver and spleen, and pelvic implants encasing the uterus and sigmoid colon.